SCHEMBL17953845

SCHEMBL17953845

c1ccc(-n2c3ccc(-c4cccc5ccccc45)cc3c3cc(-c4ccc5c6c(cccc46)-c4ccccc4-5)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ATM Q13315 2/20 0.41
▸ MCL1 Q07820 2/20 0.41
▸ ACMSD Q8TDX5 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ TLR4 O00206 1/20 0.38
▸ NTSR1 P30989 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ EDNRB P24530 1/20 0.36
▸ EDNRA P25101 1/20 0.36
▸ KEAP1 Q14145 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17953826 0.95 L3MBTL1 (0.44) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL17953925 0.94 L3MBTL1 (0.46) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL16483145 0.92 L3MBTL1 (0.39) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL17953663 0.92 L3MBTL1 (0.51) L3MBTL1KDM4EATMALDH1A1TSHR
SCHEMBL2887438 0.92 KDM4E (0.48) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL17953834 0.91 MCL1 (0.39) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL17341512 0.91 L3MBTL1 (0.38) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL17789197 0.90 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1TSHR
SCHEMBL15480206 0.90 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1TSHR
SCHEMBL17953760 0.90 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10622569-B2 Compound, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-04-14 — — US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 — — US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EFNA1, L1CAM, LEF1 L3MBTL1 1706/4885KDM4E 2030/4885ATM 3520/4885
US-10622569-B2 Compound, organic electroluminescent element, and electronic device EFNA1, L1CAM, LEF1 L3MBTL1 1706/4885KDM4E 2030/4885ATM 3520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback